HPA-1a与HPA-5b同种免疫妊娠的临床特征及HPA-5b抗体与症状性FNAIT的关联
抗HPA-1a与抗HPA-5b病例中严重出血比例相似(11% vs 10%),提示抗HPA-5b也可导致严重新生儿出血。
要点
- 抗HPA-1a与抗HPA-5b病例严重出血比例分别为11%和10%,无显著差异。
- 多孕次疑似FNAIT中,抗HPA-5b病例HPA不相容比例低于预期。
核心结论
- 抗HPA-5b可导致严重新生儿出血症状,与抗HPA-1a相似。
- 需要前瞻性研究真正评估抗HPA-5b介导FNAIT的自然史。
研究设计与样本
- 采用单克隆抗体特异性血小板抗原固定试验进行HPA抗体筛查,父母及新生儿进行对应抗原分型,通过结构化问卷收集临床数据。
主要发现
- 抗HPA-1a组严重出血比例为14/129(11%),抗HPA-5b组为4/40(10%),两组比例无差异。
- 多孕次疑似FNAIT中,抗HPA-1a病例HPA不相容比例为100%(81/81),抗HPA-5b为79%(38/48),而基于HPA等位基因分布的预期分别为86%和52%。
关键数值与推荐
- 严重出血在抗HPA-1a组为11%(14/129),抗HPA-5b组为10%(4/40)。
- 多孕次中抗HPA-5b病例HPA不相容比例为79%(38/48),高于预期52%。
临床怎么用
- 对疑似FNAIT病例应检测抗HPA-5b,因其也可能与严重出血相关。
局限性
- 回顾性设计,抗HPA-5b介导FNAIT的自然史需前瞻性研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fetal neonatal alloimmune thrombocytopenia (FNAIT) is caused by maternal alloantibodies directed against the human platelet antigens (mostly HPA-1a or HPA-5b) of the (unborn) child and can lead to severe bleeding. Anti-HPA-1a-mediated FNAIT shows a severe clinical outcome more often than anti-HPA-5b-mediated FNAIT. Given the relatively high prevalence of anti-HPA-5b in pregnant women, the detection of anti-HPA-5b in FNAIT-suspected cases may in some cases be an incidental finding. Therefore we investigated the frequency of anti-HPA-5b-associated severe bleeding in FNAIT. We performed a retrospective nationwide cohort study in cases with clinical suspicion of FNAIT. HPA antibody screening was performed using monoclonal antibody-specific immobilisation of platelet antigens. Parents and neonates were typed for the cognate antigen. Clinical data were collected by a structured questionnaire. In 1 864 suspected FNAIT cases, 161 cases (8·6%) had anti-HPA-1a and 60 (3·2%) had anti-HPA-5b. The proportion of cases with severe bleeding did not differ between the cases with anti-HPA-1a (14/129; 11%) and anti-HPA-5b (4/40; 10%). In multigravida pregnant women with a FNAIT-suspected child, 100% (81/81) of anti-HPA-1a cases and 79% (38/48) of anti-HPA-5b cases were HPA-incompatible, whereas 86% and 52% respectively were expected, based on the HPA allele distribution. We conclude that anti-HPA-5b can be associated with severe neonatal bleeding symptoms. A prospective study is needed for true assessment of the natural history of anti-HPA-5b mediated FNAIT.
引用
- de Vos TW, Porcelijn L, Hofstede-van Egmond S, et al. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia. Br J Haematol. 2021. PMID: 34402048. doi:10.1111/bjh.17731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。